Three custom development and manufacturing organizations – PCAS S.A. in France, Chemie Uetikon in Germany and PCI Synthesis in the United States – have joined forces as Seqens CDMO (formerly Novacap) to offer world-class Drug Substance Development and Manufacturing services to the pharmaceutical industry. With three R&D centers, six cGMP / FDA inspected production sites in Europe and the United States supported by two manufacturing sites for production of critical intermediates & Regulatory Starting Materials (RSMs), the group offers a manufacturing network capable to embrace complexity in developing, industrializing & manufacturing.